Ampersand names CFO and CCO

Boston-based Ampersand Capital Partners has appointed Dana Niles to chief financial officer and chief compliance officer.

This is a new role for the firm that focuses on mid-market growth equity investments in the healthcare sector, typically investing between $10 and $50 million.

Prior to the move Niles was most recently chief financial officer of HighPoint Capital, a senior debt platform. He was previously controller at healthcare-focused venture firm, HLM Venture Partners, and YankeeTek Ventures, a venture firm focusing on early stage technology companies.

Niles was not the only addition to the Ampersand management team. The firm also bolstered its investment team with the appointment of Eric Lev as partner on the deal team. Lev was most recently on the investment team of healthcare-focused private equity firm Water Street Healthcare Partners.

He is joined by John Perkins, who will take on an operating partner role with the investment team. Perkins joined from former Ampersand portfolio company Talecris Biotherapeutics, a US biotech company.

In other news, Christopher Davis has joined private equity firm Larsen MacColl Partners as chief operating officer and chief financial officer. Prior to this role Davis held a similar position at merchant bank and private equity fund management company Perseus.